Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • younko
    Member
    • May 2014
    • 24

    #1

    DESeq : without replication

    Hello

    I have a question regarding to the replicates for DESeq.

    Here is my data design..

    > head(data)

    KYM_pre KYM_post GDY_pre GDY_post HKS_pre HKS_post KWK_pre KWK_post PYM_pre PYM_post SHM_pre SHM_post
    A1BG 13 24 25 10 47 22 19 12 27 45 50 61
    A2M 3 4 4 8 37 8 19 6 4 3 7 11
    A2M-AS1 7 1 1 1 10 1 7 7 0 0 0 8
    ......


    > meta

    patient drug
    KYM_pre 1 pre
    KYM_post 1 post
    GDY_pre 2 pre
    GDY_post 2 post
    HKS_pre 3 pre
    HKS_post 3 post
    KWK_pre 4 pre
    KWK_post 4 post
    PYM_pre 5 pre
    PYM_post 5 post
    SHM_pre 6 pre
    SHM_post 6 post


    =====================================
    My goal is to find DEG responsing to the drug..

    I tried two strategy neither of them worked..

    1) Frankly, I don't have replicates.. so..
    d_rare <- newCountDataSet(data, meta)
    d_rare <- estimateSizeFactors(d_rare)
    d_rare <- estimateDispersions(d_rare, method="blind", sharingMode="fit-only")

    dh_fit1 = fitNbinomGLMs(d_rare, count ~ patient + drug)
    dh_fit0 = fitNbinomGLMs(d_rare, count ~ patient)

    Unfortunately, this model return NO DEG based on adjusted pvalue.

    2) I assumes 6 patients having same disease are biological replicates for more solid estimation for dispersion


    d_rare <- newCountDataSet(data, meta)
    d_rare <- estimateSizeFactors(d_rare)
    d_rare <- estimateDispersions(d_rare) # which means using default option (maximum likelihood estimation)

    Again, in this second trial I got the following error
    "None of your conditions is replicated. Use method='blind' to estimate across conditions, or 'pooled-CR', if you have crossed factors "

    Does anyone have an idea? I have replications for patient(e.g. 1 1 2 2 3 3 44 ...etc) and drug(pre/post) too. why I am getting this message?? My suspection is that when I consider the cross design.. for example, for fixed factor(e.g. pre) I only have one patient 1, one patient 2, one patient 3... etc.. Is this the problem??

    I also refer the DESeq manual example for pasilla Dataset.
    > pasillaDesign
    condition libType
    untreated1 untreated single-end
    untreated2 untreated single-end
    untreated3 untreated paired-end
    untreated4 untreated paired-end
    treated1 treated single-end
    treated2 treated paired-end
    treated3 treated paired-end

    In this design, they could sucessfully run. But in same way(like my model), for fixed single-end, they also only have one treated sample..

    > cdsFull = newCountDataSet( pasillaCountTable, pasillaDesign )
    > cdsFull = estimateDispersions( cdsFull )


    Maybe, I am missing something... please help me..
    Last edited by younko; 08-12-2014, 12:38 AM.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Firstly, use DESeq2 (in fact, you'll see many people using designs very similar to yours with DESeq2).

    Secondly, you do have replicates, you just also have a patient effect that you want to compensate for. It's been a while since I've used DESeq1, but the 'pooled-CR' method is probably what you want.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...